This included cells from five healthy individuals and seven sporadic PD cases from TUH cohort (Table 1), treated in vitro with or without 100 nM of LRRK2 inhibitor MLi-2 to determine if the changes observed were LRRK2 dependent. Here, LRRK2 is linked to Parkinson disease.